ZTS FY 2017 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$5.3B+8.6% YoY

Gross Profit

$3.4B64.9% margin

Operating Income

$1.7B32.5% margin

Net Income

$864M16.3% margin

EPS (Diluted)

$1.75

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.1B

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$8.6B

Total Liabilities

$6.8B

Stockholders' Equity

$1.8B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.3B	$4.9B	+8.6%
Gross Profit	$3.4B	$3.1B	+9.5%
Operating Income	$1.7B	$1.4B	+23.0%
Net Income	$864M	$821M	+5.2%